These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 24566461

  • 1. Topiramate for migraine prophylaxis in pediatric patients.
    Deaton TL, Mauro LS.
    Ann Pharmacother; 2014 May; 48(5):638-43. PubMed ID: 24566461
    [Abstract] [Full Text] [Related]

  • 2. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 May; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 3. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
    Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.
    Pain Med; 2008 Mar; 9(2):175-85. PubMed ID: 18298700
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
    Lewis D, Paradiso E.
    Headache; 2007 Mar; 47(10):1409-17. PubMed ID: 18052950
    [Abstract] [Full Text] [Related]

  • 5. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.
    Health Qual Life Outcomes; 2007 Oct 04; 5():56. PubMed ID: 17916258
    [Abstract] [Full Text] [Related]

  • 6. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS.
    Headache; 2006 Oct 04; 46(10):1503-10. PubMed ID: 17115983
    [Abstract] [Full Text] [Related]

  • 7. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.
    Lakshmi CV, Singhi P, Malhi P, Ray M.
    J Child Neurol; 2007 Jul 04; 22(7):829-35. PubMed ID: 17715274
    [Abstract] [Full Text] [Related]

  • 8. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials.
    Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J.
    CNS Spectr; 2003 Jun 04; 8(6):428-32. PubMed ID: 12858132
    [Abstract] [Full Text] [Related]

  • 9. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 10. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 25; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 11. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2002 Sep 25; 42(8):796-803. PubMed ID: 12390644
    [Abstract] [Full Text] [Related]

  • 12. Topiramate: a case series study in migraine prophylaxis.
    Young WB, Hopkins MM, Shechter AL, Silberstein SD.
    Cephalalgia; 2002 Oct 25; 22(8):659-63. PubMed ID: 12383061
    [Abstract] [Full Text] [Related]

  • 13. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J, Campos J, Casas C, Herranz JL.
    J Child Neurol; 2005 Mar 25; 20(3):251-3. PubMed ID: 15832623
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
    Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L.
    Pediatrics; 2009 Mar 25; 123(3):924-34. PubMed ID: 19255022
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 25; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 19. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 25; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 20. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G, Usai S, D'Amico D.
    Neurol Sci; 2006 May 25; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.